Article
Clinicopathological and Prognostic Significance of CD44s and CD44v6 Expression in Patients with Glioma: A Systematic Review and Meta-analysis
2020-06-30
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>: Cancer stem cell surface marker CD44 has been revealed to promote tumor growth, progression, and metastasis in gliomas. Although the prognostic and clinicopathological value of CD44 standard form (CD44s) and its variant isoform CD44v6 expression in glioma patients has been evaluated in several independent studies, their results remained controversial. Therefore,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 160db898-0ad0-5f2d-aebd-741a9c235f6e
- DOI
- 10.21203/rs.3.rs-38156/v1
